Journal Home > Volume 2 , Issue 2
Cancer Innovation 2023, 2(2): 91-95 https://doi.org/10.1002/cai2.65
Commentary | Open Access | Issue | Published: 13 April 2023

High BRCA1 expression is an independent prognostic biomarker in LUAD and correlates with immune infiltration

Show Author's Information Fengzhu Guo1,2,  Cong Li1,  Shuning Liu1,  Zhijun Li1,  Jingtong Zhai1,  Zhiwu Wang3( ),  Binghe Xu1( )
Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
Department of Medical Oncology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China
Department of Chemoradiotherapy, Tangshan People's Hospital, Tangshan, China
Keywords:
prognosis, lung adenocarcinoma, bioinformatics analysis, meta‐analysis, non‐small‐cell lung cancer
Cite this article:
Guo F, Li C, Liu S, et al. High BRCA1 expression is an independent prognostic biomarker in LUAD and correlates with immune infiltration. Cancer Innovation, 2023, 2(2): 91-95. https://doi.org/10.1002/cai2.65
Download citation
EndNote(RIS)
BibTeX

278

Views

14

Downloads

Citations

1

Crossref

N/A

WoS

1

Scopus

N/A

CSCD

Full text About this article

menu
Full text
Outline
About this article

High BRCA1 expression is an independent prognostic biomarker in LUAD and correlates with immune infiltration

Show Author's information Fengzhu Guo1,2, Cong Li1, Shuning Liu1, Zhijun Li1, Jingtong Zhai1, Zhiwu Wang3( ), Binghe Xu1( )
Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
Department of Medical Oncology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China
Department of Chemoradiotherapy, Tangshan People's Hospital, Tangshan, China
Keywords: prognosis, lung adenocarcinoma, bioinformatics analysis, meta‐analysis, non‐small‐cell lung cancer

References(5)

1

Miller KD, Nogueira L, Devasia T, Mariotto AB, Yabroff KR, Jemal A, et al. Cancer treatment and survivorship statistics, 2022. CA Cancer J Clin. 2022;72(5): 409–36. https://doi.org/10.3322/caac.21731
DOI Google Scholar
2

Moynahan ME, Chiu JW, Koller BH, Jasin M. Brca1 controls homology‐directed DNA repair. Mol Cell. 1999;4(4): 511–8. https://doi.org/10.1016/S1097-2765(00)80202-6
DOI Google Scholar
3

Hashemi Sadraei N, Feng Y, Du L, Fu P, Haque S, Dowlati A, et al. High UDG and BRCA1 expression is associated with adverse outcome in patients with pemetrexed treated non‐small cell lung cancer. Lung Cancer. 2018;126:48–54. https://doi.org/10.1016/j.lungcan.2018.08.011
DOI Google Scholar
4

Wang GH, Zhao CM, Huang Y, Wang W, Zhang S, Wang X. BRCA1 and BRCA2 expression patterns and prognostic significance in digestive system cancers. Hum Pathol. 2018;71:135–44. https://doi.org/10.1016/j.humpath.2017.10.032
DOI Google Scholar
5

Ludovini V, Ricciuti B, Tofanetti F, Mencaroni C, Giannarelli D, Sidoni A, et al. KRAS mutation and DNA repair and synthesis genes in non‐small‐cell lung cancer. Mol Clin Oncol. 2018;9(6): 689–96. https://doi.org/10.3892/mco.2018.1731
DOI Google Scholar
Publication history
Copyright
Acknowledgements
Rights and permissions

Publication history

Published: 13 April 2023
Issue date: April 2023

Copyright

© 2023 The Authors.

Acknowledgements

ACKNOWLEDGMENTS

The authors would like to express our sincere thanks for sharing the data from the Cancer Genome Atlas (LUAD and LUSC), Genotype‐Tissue Expression (lung tissue), Human Protein Atlas (lung tissue), and Gene Expression Omnibus (GSE41271). This study was supported by the CAMS Innovation Fund for Medical Sciences (CIFMS, 2021‐I2M‐1‐014).

Rights and permissions

This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

Return